{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:30:39Z","timestamp":1793377839889,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101100","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:15:07Z","timestamp":1791990907000},"page":"101100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MAP2K1-mutated melanocytic tumors: correlation of histological features with their molecular functional class based on a study of 114 cases"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-3166","authenticated-orcid":false,"given":"Laura","family":"Gadeyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boulos","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Waldenb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siebe","family":"Loontiens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"De Ryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Creytens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lemahieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Bassarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Taibjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Daruish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Siozopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Goutas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"De la Fouchardi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Kazakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Alomari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.modpat.2026.101100_bib1","doi-asserted-by":"crossref","first-page":"20411","DOI":"10.1073\/pnas.0905833106","article-title":"MEK1 mutations confer resistance to MEK and B-RAF inhibition","volume":"106","author":"Emery","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.modpat.2026.101100_bib2","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-12-0383","article-title":"Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance","volume":"19","author":"Pritchard","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101100_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjd.19118","article-title":"A mosaic variant in MAP2K1 is associated with giant naevus spilus-type congenital melanocytic naevus and melanoma development","volume":"183","author":"Muthiah","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101100_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.1026","article-title":"Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma","volume":"44","author":"Nikolaev","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/DAD.0000000000001795","article-title":"Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology","volume":"42","author":"Sunshine","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101100_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00428-020-02940-3","article-title":"Expanding spectrum of \"spitzoid\" lesions: a small series of 4 cases with MAP2K1 mutations","volume":"479","author":"Kerckhoffs","year":"2021","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.modpat.2026.101100_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/DAD.0000000000001840","article-title":"MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology","volume":"43","author":"Donati","year":"2021","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/cup.14502","article-title":"MAP2K1-mutated melanocytic tumors have reproducible histopathologic features and share similarities with melanocytic tumors with BRAF V600E mutations","volume":"50","author":"Alomari","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/PAS.0000000000002131","article-title":"Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1","volume":"47","author":"Fumero-Vel\u00e1zquez","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101100_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-17-1452","article-title":"Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties","volume":"8","author":"Gao","year":"2018","journal-title":"Cancer Discovery"},{"issue":"2","key":"10.1016\/j.modpat.2026.101100_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/1535-7163.MCT-22-0302","article-title":"High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer","volume":"22","author":"Mizuno","year":"2023","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.modpat.2026.101100_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PAS.0000000000001195","article-title":"Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 Cases","volume":"43","author":"Isales","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101100_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/PAS.0000000000000902","article-title":"Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes","volume":"41","author":"Cohen","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101100_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.101100_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105643","article-title":"Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours","volume":"114","author":"Ebbelaar","year":"2025","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.modpat.2026.101100_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41379-020-00658-w","article-title":"Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms","volume":"34","author":"Gerami","year":"2021","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101100_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100264","article-title":"GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related Melanomas","volume":"36","author":"Kervarrec","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101100_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/his.15474","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour","author":"Cordier","year":"2025","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.modpat.2026.101100_bib19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/nar\/gky1263","article-title":"WisecondorX: improved copy number detection for routine shallow whole-genome sequencing","volume":"47","author":"Raman","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.101100_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41379-019-0384-8","article-title":"Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations","volume":"33","author":"Houlier","year":"2020","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101100_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/cup.13533","article-title":"CRTC1-TRIM11 fusion defined melanocytic tumors: A series of four cases","volume":"46","author":"Ko","year":"2019","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101100_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/pcmr.13004","article-title":"RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features","volume":"34","author":"Houlier","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"issue":"19","key":"10.1016\/j.modpat.2026.101100_bib23","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1158\/0008-5472.CAN-20-0865","article-title":"Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer","volume":"80","author":"Hanrahan","year":"2020","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.modpat.2026.101100_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00000478-199907000-00006","article-title":"Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma","volume":"23","author":"Harris","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101100_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/DAD.0b013e3181e5dfa0","article-title":"Desmoplastic nevus: An entity distinct from spitz nevus and blue nevus","volume":"33","author":"Sherrill","year":"2011","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101100_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1535370220959657","article-title":"Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database","volume":"246","author":"Owsley","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"10.1016\/j.modpat.2026.101100_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jtho.2020.05.021","article-title":"Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations","volume":"15","author":"Negrao","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101100_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/DAD.0000000000003056","article-title":"The Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms","volume":"47","author":"Addo","year":"2025","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101100_bib29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000002262","article-title":"PRKC Fusion Melanocytic Tumors, a Subgroup of Melanocytic Tumors More Closely Aligned to Blue Nevi Than to PRKAR1A-inactivated Pigmented Epithelioid Melanocytomas","volume":"48","author":"Patel","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101100_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cup.14801","article-title":"Genomic and Transcriptomic Characterization of Protein Kinase C Fusion Melanocytic Neoplasms With Distinctive Hypopigmented Histomorphology: A Single-Institution Study","volume":"52","author":"Li","year":"2025","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101100_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100469","article-title":"Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors","volume":"37","author":"Cloutier","year":"2024","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13123066","article-title":"NGS-Based Analysis of Atypical Deep Penetrating Nevi","volume":"13","author":"Manca","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.modpat.2026.101100_bib33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41379-022-01026-6","article-title":"Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing","volume":"35","author":"Ebbelaar","year":"2022","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib34","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41379-020-0581-5","article-title":"Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations","volume":"33","author":"Williams","year":"2020","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101100_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/DAD.0000000000001754","article-title":"Desmoplastic Melanomas Mimicking Neurofibromas","volume":"42","author":"Gerami","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101100_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/cas.14699","article-title":"Multiple mutations within individual oncogenes","volume":"112","author":"Saito","year":"2021","journal-title":"Cancer science"},{"key":"10.1016\/j.modpat.2026.101100_bib37","article-title":"Sclerosing melanocytic tumors with MAP2K1 in frame deletions and 15q gains: A distinctive pathway of nevogenesis with reproducible morphology","author":"Friedman","year":"2025","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.modpat.2026.101100_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cup.14586","article-title":"Sclerosing melanocytic tumors with MAP2K1 in-frame deletions and copy number gains in 15q: A distinctive pathway of nevogenesis","volume":"51","author":"Hamad","year":"2024","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101100_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101100_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/PAS.0000000000001683","article-title":"Expanding Our Understanding of Nevogenesis: Copy Number Gain of Chromosome 15q in Melanocytic Nevi Is Associated With Distinct Histomorphologic Findings","volume":"45","author":"Olson","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"10.1016\/j.modpat.2026.101100_bib41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2012.44.7888","article-title":"Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma","volume":"31","author":"Trunzer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.modpat.2026.101100_bib42","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2010.33.2312","article-title":"Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling","volume":"29","author":"Wagle","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101100_bib43","article-title":"Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers","volume":"9","author":"Dankner","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101100_bib44","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.3390\/ijms24054520","article-title":"Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma","volume":"24","author":"Krebs","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:31:37Z","timestamp":1793374297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S0893395226001432"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101100","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAP2K1-mutated melanocytic tumors: correlation of histological features with their molecular functional class based on a study of 114 cases","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101100"}}